- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01734291
Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression
Brief Multifamily Psychoeducation for Families of Patients With Chronic Major Depression: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Major depressive disorder (MDD) is a long-lasting illness with significant effects on the patient's family, social life, and work life. Treatment failure results in a low recovery rate and frequent relapses.
Relatives of patients with MDD are fraught with heavy psychosocial burden and show increased rates of depression and anxiety. Among relatives of patients with MDD, the patient's behavior and mood disturbance and relative's emotional distress were associated with the relatives' burden.
Family psychoeducation is recognized as part of the optimal treatment for patients with psychotic disorder. This intervention has been shown to reduce the rates of relapse and hospitalization among individuals with psychotic disorders and is recognized as an evidenced-based treatment for psychotic disorder. Several randomized controlled trials have found that family psychoeducation is effective in enhancing the course of bipolar disorder. However, there are few studies on psychoeducation of families of patients with MDD.
The purpose of this study is to examine the effectiveness of brief multifamily psychoeducation to relieve the psychological distress of families of patients with chronic major depression and to improve their family functioning, in a randomized controlled trial.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Aichi
-
Nagoya, Aichi, Japan, 467-8601
- Fujika Katsuki
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Meets the criteria for Major Depressive Disorder (MDD) according to DSM-IV.
- Receives antidepressant therapy.
- The patient had the first episode of MDD more than one year ago.
- Currently fulfills the diagnostic threshold for major depressive episode or partial remission.
- The patient and their family member(s) are aged between 18 and 85 years.
- The patient has lived with his/her family at the time of participating in this study and is expected to live with his/her family during the investigation period.
Exclusion Criteria:
- Patients who undergo electroconvulsive therapy (ECT) during the investigation period.
- Patients who are at serious suicidal risk.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Family psychoeducation plus TAU
Family psychoeducational therapy in addition to treatment as usual for the patients.
|
Family psychoeducational therapy every two weeks for six weeks in addition to treatment as usual administered by physicians
|
Placebo Comparator: Treatment as usual(TAU)
Treatment as usual administered by physician and counseling administered by nurse.
|
Family psychoeducational therapy every two weeks for six weeks in addition to treatment as usual administered by physicians
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of total score of K6 of family members
Time Frame: The base line, 8, 16 and 32
|
The K6 questionnaire is a six-item self-report questionnaire that was developed to screen for DSM-IV depressive and anxiety disorder.
|
The base line, 8, 16 and 32
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of total score of Family Attitude Scale(FAS) of family members
Time Frame: The base line, 8, 16 and 32
|
The Family Attitude Scale(FAS) is a 30-item self report inventory and measures families' Expressed Emotion(EE).
|
The base line, 8, 16 and 32
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fujika Katsuki, Dr, Nagoya City University, School of Nursing
Publications and helpful links
General Publications
- Katsuki F, Takeuchi H, Watanabe N, Shiraishi N, Maeda T, Kubota Y, Suzuki M, Yamada A, Akechi T. Multifamily psychoeducation for improvement of mental health among relatives of patients with major depressive disorder lasting more than one year: study protocol for a randomized controlled trial. Trials. 2014 Aug 12;15:320. doi: 10.1186/1745-6215-15-320.
- Katsuki F, Takeuchi H, Inagaki T, Maeda T, Kubota Y, Shiraishi N, Tabuse H, Kato T, Yamada A, Watanabe N, Akechi T, Furukawa TA. Brief multifamily Psychoeducation for family members of patients with chronic major depression: a randomized controlled trial. BMC Psychiatry. 2018 Jun 22;18(1):207. doi: 10.1186/s12888-018-1788-6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCUPsychiatricNursing001
- ID24593499 (Other Grant/Funding Number: Grants-in-Aid for Scientific Research)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on Family psychoeducation
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedPsychosisUnited States, Canada
-
Duke UniversityNational Institute of Mental Health (NIMH)CompletedSchizophrenia Spectrum and Other Psychotic Disorders | Mental Disorders, SevereTanzania
-
Brown UniversityCompletedAdolescent Substance UseUnited States
-
University of California, Los AngelesStanford University; University of Colorado, BoulderCompletedBipolar Disorder | Major Depressive DisorderUnited States
-
University of CagliariCompletedSchizophrenia and Related Disorders | Patient Non-ComplianceItaly
-
Dartmouth-Hitchcock Medical CenterNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Bipolar Disorder | Substance-related DisordersUnited States
-
Nagoya City UniversityAichi Health Promotion FoundationCompleted
-
Vanderbilt UniversityNationwide Children's HospitalRecruiting
-
Anne Katrine PagsbergCopenhagen Trial Unit, Center for Clinical Intervention Research; Danish Research...Active, not recruitingObsessive-Compulsive Disorder in Children | Obsessive-Compulsive Disorder in AdolescenceDenmark
-
Brown UniversityCompletedSubstance Use | Risky Sexual BehaviorUnited States